Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVKD Cadrenal Therapeutics, Inc.

交易中 07-19 12:13:49 EDT

0.4300

-0.0097

-2.21%

最高0.4400	最低0.4300	成交量5.16万
今开0.4315	昨收0.4397	日振幅2.27%
总市值688.36万	流通市值308.70万	总股本1,601万
成交额2.24万	换手率0.72%	流通股本717.91万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":0.43,"timestamp":1721405322712,"preClose":0.4397,"halted":0,"volume":51634,"delay":0,"floatShares":7179090,"shares":16008469,"eps":-0.327464,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0097,"latestTime":"07-19 12:13:49 EDT","open":0.4315,"high":0.44,"low":0.43,"amount":22396.721500120002,"amplitude":0.022743,"askPrice":0.4343,"askSize":454,"bidPrice":0.43,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.327464,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721419200000},"adr":0,"listingDate":1674190800000,"adjPreClose":0.4397,"postHourTrading":{"tag":"盘后","latestPrice":0.44,"preClose":0.434,"latestTime":"17:18 EDT","volume":1295,"amount":568.8595,"timestamp":1721337521271},"volumeRatio":1.230737},"requestUrl":"/m/hq/s/CVKD/tweets","defaultTab":"tweets","newsList":[{"id":"2448648041","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.45%报0.490美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448648041","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448648041?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:35","pubTimestamp":1719938159,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时35分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速拉升5.45%。截至发稿，该股报0.490美元/股，成交量5.9771万股，换手率0.37%，振幅4.30%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070300360096818dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070300360096818dd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CVKD"],"gpt_icon":0},{"id":"2444040212","title":"Cadrenal Therapeutics, Inc.盘中异动 急速拉升5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444040212","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444040212?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:41","pubTimestamp":1718890916,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时41分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅拉升5.94%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214157aef5da92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214157aef5da92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CVKD","BK4007"],"gpt_icon":0},{"id":"2444843110","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.60%报0.472美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444843110","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444843110?lang=zh_cn&edition=full","pubTime":"2024-06-18 22:37","pubTimestamp":1718721452,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日22时37分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速下跌5.60%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618223732941ef3e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618223732941ef3e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CVKD","BK4007"],"gpt_icon":0},{"id":"2444193497","title":"Cadrenal Therapeutics, Inc.盘中异动 急速拉升5.17%报0.505美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444193497","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444193497?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:20","pubTimestamp":1718634022,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时20分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅上涨5.17%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617222022af8de46e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617222022af8de46e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2443131605","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨6.14%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443131605","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443131605?lang=zh_cn&edition=full","pubTime":"2024-06-15 01:30","pubTimestamp":1718386209,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日01时30分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅上涨6.14%。截至发稿，该股报0.470美元/股，成交量3.3835万股，换手率0.21%，振幅4.52%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013009af8da65b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013009af8da65b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2441509476","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌7.76%报0.461美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441509476","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441509476?lang=zh_cn&edition=full","pubTime":"2024-06-08 01:43","pubTimestamp":1717782219,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日01时43分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌7.76%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608014339af8cae14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608014339af8cae14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CVKD","LENZ"],"gpt_icon":0},{"id":"2441710870","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速跳水5.49%报0.482美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441710870","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441710870?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:32","pubTimestamp":1717680720,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时32分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速下跌5.49%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213200941ecf7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213200941ecf7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CVKD"],"gpt_icon":0},{"id":"2441230139","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅跳水5.43%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441230139","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441230139?lang=zh_cn&edition=full","pubTime":"2024-06-05 00:04","pubTimestamp":1717517063,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日00时04分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速跳水5.43%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605000424af8bf1b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605000424af8bf1b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2440495347","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440495347","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440495347?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:31","pubTimestamp":1717421466,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时31分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213107aef30cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213107aef30cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CVKD"],"gpt_icon":0},{"id":"2440910652","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨6.24%报0.436美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440910652","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440910652?lang=zh_cn&edition=full","pubTime":"2024-06-01 00:52","pubTimestamp":1717174347,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日00时52分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速上涨6.24%。截至发稿，该股报0.436美元/股，成交量4.2292万股，换手率0.26%，振幅3.63%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601005227af8b6b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601005227af8b6b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CVKD","BK4007","BK4139"],"gpt_icon":0},{"id":"2434289644","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434289644","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434289644?lang=zh_cn&edition=full","pubTime":"2024-05-11 03:57","pubTimestamp":1715371020,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日03时57分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅跳水5.23%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110357017a594622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110357017a594622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CVKD"],"gpt_icon":0},{"id":"2431899998","title":"Cadrenal Therapeutics, Inc.盘中异动 临近午盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431899998","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431899998?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:36","pubTimestamp":1714404963,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时36分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.81%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292336047a573d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292336047a573d5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2429165149","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429165149","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429165149?lang=zh_cn&edition=full","pubTime":"2024-04-24 02:54","pubTimestamp":1713898471,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日02时54分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速上涨5.57%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.71%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042402543187e82e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042402543187e82e60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2429927419","title":"Cadrenal Therapeutics, Inc.盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429927419","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429927419?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:22","pubTimestamp":1713795744,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时22分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222222487e82854&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222222487e82854&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CVKD","BK4139","LENZ"],"gpt_icon":0},{"id":"2428965470","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大跌6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428965470","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428965470?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:37","pubTimestamp":1713533827,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时37分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌6.91%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192137077a541c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192137077a541c20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2428259756","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘急速跳水5.24%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428259756","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428259756?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:02","pubTimestamp":1713448931,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时02分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅下挫5.24%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418220211861e7158&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418220211861e7158&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2428349106","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速拉升5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428349106","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428349106?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:49","pubTimestamp":1713361771,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时49分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速上涨5.67%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721493187e81613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721493187e81613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CVKD","BK4139","LENZ"],"gpt_icon":0},{"id":"2428280811","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.93%报0.381美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428280811","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428280811?lang=zh_cn&edition=full","pubTime":"2024-04-17 01:17","pubTimestamp":1713287831,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日01时17分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌5.93%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170117117a533230&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170117117a533230&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CVKD"],"gpt_icon":0},{"id":"2426093780","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426093780","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426093780?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:31","pubTimestamp":1712928664,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时31分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌5.30%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213104876f4537&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213104876f4537&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","LENZ","BK4007"],"gpt_icon":0},{"id":"2426695268","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘急速下挫9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426695268","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426695268?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:32","pubTimestamp":1712842329,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时32分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅下挫9.29%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132108767fa8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132108767fa8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CVKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cadrenal.com","stockEarnings":[{"period":"1week","weight":-0.0746},{"period":"1month","weight":-0.0892},{"period":"3month","weight":0.0807},{"period":"6month","weight":-0.5786},{"period":"1year","weight":-0.6712},{"period":"ytd","weight":-0.4134}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":0.0076},{"period":"3month","weight":0.1161},{"period":"6month","weight":0.1456},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cadrenal Therapeutics, Inc.于2022年1月25日注册为特拉华州公司。他们专注于开发Tecarfarin，这是一种具有孤儿药适应症的新型疗法，旨在预防终末期肾病患者的心源性全身性血栓栓塞（血凝块）和心房颤动（心律不齐）或 AFib。Tecarfarin 是一种抗凝剂，其药物设计过程针对与血栓形成和 AFib 治疗中最常用的处方药不同的途径。他们于2022年4月1日通过 Horizon Technology Finance Corporation的全资子公司HESP LLC的资产购买协议获得了tecarfarin的权利。","exchange":"NASDAQ","name":"Cadrenal Therapeutics, Inc.","nameEN":"Cadrenal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cadrenal Therapeutics, Inc.,CVKD,Cadrenal Therapeutics, Inc.股票,Cadrenal Therapeutics, Inc.股票老虎,Cadrenal Therapeutics, Inc.股票老虎国际,Cadrenal Therapeutics, Inc.行情,Cadrenal Therapeutics, Inc.股票行情,Cadrenal Therapeutics, Inc.股价,Cadrenal Therapeutics, Inc.股市,Cadrenal Therapeutics, Inc.股票价格,Cadrenal Therapeutics, Inc.股票交易,Cadrenal Therapeutics, Inc.股票购买,Cadrenal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}